US 10226454
Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
granted A61KA61K31/4465A61P
Quick answer
US patent 10226454 (Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound) held by Theravance Biopharma R&D IP, LLC expires Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Theravance Biopharma R&D IP, LLC
- Grant date
- Tue Mar 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4465, A61P, A61P11/06, A61P13/00